The following summarizes the serious toxicity caused by PI3K inhibitors in clinic (Table 3), including hyperglycaemia, cutaneous reactions, diarrhoea/colitis, pneumonitis, hepatotoxicity and hypertension. This evidence concerns the gene PIK3CA and pneumonitis.